XTALPI and Deep Principle Forge Strategic Alliance to Revolutionize Materials Discovery with AI-Powered Robotic Platform

Recently, XtalPi(XtalPi Holdings Limited-P, XTALPI-P, Stock Code: 2228.HK)Strategic cooperation reached with Deep Principle, a star technology innovation company. Leveraging the technical advantages of XtalPi's AI + robotics platform and the expertise of both parties, the collaboration will focus on intelligent and automated R&D in the field of chemical materials. Together, they will create a next-generation, full-chain intelligent material R&D platform that integrates new molecular design, reaction pathway design, reaction synthesis optimization, and high-throughput automated workstation capabilities. This platform is expected to complete the full closed-loop process from material discovery, property prediction, formulation optimization to controlled experiments in a shorter time, establishing a new R&D paradigm that is "faster, more accurate, and more cost-effective."

Also originating from MIT, as an emerging force in the AI-driven chemical field, Deep Principle was co-founded by Dr. Haojun Jia, founder and CEO, and Dr. Chenru Duan, founder and CTO. It is committed to accelerating innovation in material chemistry through AI technology, and by applying AI decision-making models and generative AI in chemical reactions, it aims to revolutionize the traditional "top-down experimental trial-and-error" approach to chemical material discovery.

As a strategic investor of XtalPi, in addition to capital support, it also empowers in technology and commercial transformation, jointly accelerating the development of new chemical reactions and new materials, exploring broader chemical space and innovative synthesis pathways, and speeding up the development and commercialization of new technologies and new molecules.

As the 2024 Nobel Prizes in Physics and Chemistry were successively announced, artificial intelligence once again captured widespread attention. As a general-purpose technology, AI has moved from laboratories to various fields of industrial application, leading technological advancements, transforming research paradigms, and empowering industries across the board.

As a pioneering platform technology company that has大规模 applied artificial intelligence technology in the biopharmaceutical field and gradually expanded to industries such as new materials, fine chemicals, and new energy, XtalPi has independently developed an AI robot innovation R&D platform for future industries based on quantum physics, empowered by artificial intelligence, and driven by robotic technology. It has made breakthrough progress in intelligent chemistry (AI for Chemistry) and intelligent materials (AI for Materials).

In order to benefit more fields with the innovative achievements of cutting-edge technologies,XtalPi leverages the advantages of a platform enterprise to create a comprehensive technical service platform that integrates innovative technologies, innovative models, and high-quality data. On one hand, it has built and scaled up the deployment of an AI robot laboratory from scratch, continuously producing and accumulating experimental data from the real world.Using these high-quality data, XtalPi has successfully developed and trained multiple vertical domain models, which have already generated value in specific industries and gained recognition from customers both in China and internationally.

On the other hand,XtalPi Engages in In-Depth Exchanges and Collaborations with World-Class Research Institutions, Promoting the Transformation of More Innovative Achievements from Laboratories to Industry through Synergistic Innovation between Academia and Industry.Such as jointly exploring with the Department of Chemistry at MIT to use AI + robotics platforms to drive the construction of a new paradigm for scientific intelligence (AI For Science) in chemical and materials science research; collaborating with Singapore's National Drug Discovery and Development Center (EDDC) to advance innovative drug development for non-small cell lung cancer, etc.

At the same time,XtalPi will also share its self-developed technology platform with more partners, collaborate with partners in specific fields, leverage the strengths of these fields, and solve specific problems in industrial applications.Such as cooperating with Deep Potential Technology to jointly build a new ecosystem for drug research and development based on AI4S; reaching a strategic cooperation with Yaosu Technology to promote new drug research and development based on AI + organ chips; cooperating with Sinopec Shanghai Research Institute of Petrochemicals to focus on solving the problems of "green production" and "quality improvement and efficiency enhancement" in catalyst research and development; and cooperating with GCL Group to promote the "green and efficient research and development" of high-tech new energy materials, etc.

XtalPi continuously refines artificial intelligence and robotic experimental technologies, explores cutting-edge technology application scenarios, expands the empowerment fields of its innovative R&D platform, and collaborates with more industry-academia-research partners to jointly build a technological river and an innovation powerhouse for the digital and intelligent transformation and upgrading of future industries.